# ZNF418

## Overview
ZNF418 is a gene that encodes the zinc finger protein 418, a member of the KRAB/C2H2 zinc finger protein family, which functions primarily as a transcriptional repressor. The protein is characterized by a KRAB (Kruppel-associated box) domain and 17 tandem C2H2-type zinc finger motifs, which enable it to bind specific DNA sequences and regulate gene expression (Li2007ZNF418). ZNF418 plays a crucial role in modulating various cellular pathways, including the MAPK signaling pathway, and is involved in the regulation of the ubiquitin-proteasome system and the autophagy-lysosomal pathway (Singh2020A). The protein is predominantly localized in the nucleus, consistent with its role in transcriptional regulation, and is expressed in multiple tissues such as the heart, skeletal muscle, pancreas, and liver (Li2007ZNF418). Alterations in ZNF418 expression have been linked to several diseases, including various cancers and cardiac conditions, highlighting its potential as a therapeutic target (Wang2019miR1204; Pan2017Zincfinger).

## Structure
The ZNF418 protein is composed of 676 amino acids and has a calculated molecular mass of approximately 78 kDa (Li2007ZNF418). It features a KRAB (Kruppel-associated box) motif at its amino terminus, which is involved in transcriptional repression, and 17 tandem C2H2-type zinc finger motifs at its carboxyl terminus (Li2007ZNF418). These zinc finger motifs are characterized by a consensus sequence of CX2CX3FX5LX2HX3H, where X represents any amino acid, and are known to bind to specific DNA sequences, facilitating the protein's role as a transcriptional repressor (Li2007ZNF418).

The KRAB domain can be subdivided into KRAB-A and KRAB-B boxes, with the KRAB-A motif being essential for mediating repression (Li2007ZNF418). The KRAB-A box of ZNF418 shows high homology to the consensus sequence of the KRAB-A domain, including conserved motifs DV and MLE, which are important for repression and interaction with TIF1b (Li2007ZNF418). The protein is primarily localized in the nucleus, indicating its role in transcriptional regulation (Li2007ZNF418). There is no specific information on post-translational modifications or splice variant isoforms in the provided context.

## Function
ZNF418, a member of the KRAB/C2H2 zinc finger protein family, functions primarily as a transcriptional repressor in healthy human cells. It contains a KRAB-A box and 17 tandem C2H2 zinc finger motifs, which facilitate its role in DNA binding and transcriptional regulation (Li2007ZNF418). ZNF418 is involved in modulating the MAPK signaling pathway, acting as a negative regulator by repressing transcriptional activities of genes such as the c-fos serum response element (SRE) and activation protein 1 (AP-1) (Li2007ZNF418). This repression is achieved through interactions with proteins like TIF1b, which alter chromatin structure to inhibit transcription (Li2007ZNF418).

In addition to its role in transcriptional repression, ZNF418 is a significant regulator of the ubiquitin-proteasome system (UPS) and the autophagy-lysosomal pathway (ALP). It negatively regulates UPS activity while positively influencing ALP, thereby playing a dual role in protein degradation pathways (Singh2020A). ZNF418 is localized in the nucleus, consistent with its function as a transcription factor, and is expressed in multiple tissues, including the heart, skeletal muscle, pancreas, and liver, during both embryonic and adult stages (Li2007ZNF418).

## Clinical Significance
Alterations in the expression of the ZNF418 gene have been implicated in several diseases, particularly various forms of cancer and cardiac conditions. In hepatocellular carcinoma (HCC), ZNF418 is downregulated, which is associated with increased tumor proliferation and reduced apoptosis. This downregulation is mediated by miR-1204, which targets ZNF418, leading to the activation of MAPK and c-Jun/AP1 signaling pathways, contributing to HCC progression (Wang2019miR1204).

In gastric carcinoma, ZNF418 expression is significantly reduced in cancerous tissues compared to noncancerous tissues. This downregulation correlates with advanced tumor-node-metastasis (TNM) stages and poorer overall survival, suggesting that ZNF418 could serve as a prognostic biomarker for gastric cancer (Hui2018&lt; em&gt; ZNF418&lt).

ZNF418 also plays a role in cardiac health. It is downregulated in conditions such as dilated cardiomyopathy (DCM) and hypertrophic cardiomyopathy (HCM), as well as in cardiac hypertrophy. Overexpression of ZNF418 has been shown to protect against cardiac hypertrophy and fibrosis, indicating its potential therapeutic significance in treating these conditions (Pan2017Zincfinger).

## Interactions
ZNF418, a zinc finger protein, is involved in various interactions that influence cellular processes. It acts as a transcriptional repressor, particularly affecting the MAPK signaling pathway by repressing the transcriptional activities of genes such as the c-fos serum response element (SRE) and activation protein 1 (AP-1) (Li2007ZNF418). ZNF418's KRAB motif serves as the basal repressive domain, suggesting its interaction with specific DNA sequences to mediate these effects (Li2007ZNF418).

In the context of cardiac hypertrophy, ZNF418 interacts with the c-Jun/AP-1 pathway. Overexpression of ZNF418 reduces c-Jun phosphorylation, while its deficiency increases it, indicating a regulatory role in this signaling pathway (Pan2017Zincfinger). This interaction suggests that ZNF418 may influence protein interactions and signaling pathways involved in cardiac hypertrophy (Pan2017Zincfinger).

ZNF418 is also identified as a regulator of the ubiquitin-proteasome system (UPS) and the autophagy-lysosomal pathway (ALP). It negatively regulates UPS activity and positively regulates ALP activity, affecting the expression of genes involved in ubiquitination and autophagy (Singh2020A). These interactions highlight ZNF418's role in protein degradation pathways and its potential impact on cellular homeostasis (Singh2020A).


## References


[1. (Wang2019miR1204) Liang Wang, Liankang Sun, Yufeng Wang, Bowen Yao, Runkun Liu, Tianxiang Chen, Kangsheng Tu, Qingguang Liu, and Zhikui Liu. Mir-1204 promotes hepatocellular carcinoma progression through activating mapk and c-jun/ap1 signaling by targeting znf418. International Journal of Biological Sciences, 15(7):1514–1522, 2019. URL: http://dx.doi.org/10.7150/ijbs.33658, doi:10.7150/ijbs.33658. This article has 19 citations and is from a peer-reviewed journal.](https://doi.org/10.7150/ijbs.33658)

[2. (Pan2017Zincfinger) Liming Pan, Mengting Sheng, Zirui Huang, Zhilin Zhu, Chunli Xu, Lin Teng, Ling He, Chen Gu, Cai Yi, and Junming Li. Zinc-finger protein 418 overexpression protects against cardiac hypertrophy and fibrosis. PLOS ONE, 12(10):e0186635, October 2017. URL: http://dx.doi.org/10.1371/journal.pone.0186635, doi:10.1371/journal.pone.0186635. This article has 9 citations and is from a peer-reviewed journal.](https://doi.org/10.1371/journal.pone.0186635)

[3. (Singh2020A) Sonia R Singh, Moritz Meyer-Jens, Erda Alizoti, W Clark Bacon, Gregory Davis, Hanna Osinska, James Gulick, Silke Reischmann-Düsener, Ellen Orthey, Patrick M McLendon, Jeffery D Molkentin, Saskia Schlossarek, Jeffrey Robbins, and Lucie Carrier. A high-throughput screening identifies znf418 as a novel regulator of the ubiquitin-proteasome system and autophagy-lysosomal pathway. Autophagy, 17(10):3124–3139, December 2020. URL: http://dx.doi.org/10.1080/15548627.2020.1856493, doi:10.1080/15548627.2020.1856493. This article has 16 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1080/15548627.2020.1856493)

[4. (Li2007ZNF418) Yongqing Li, Dan Yang, Yan Bai, Xiaoyang Mo, Wen Huang, Wuzhou Yuan, Zhaochu Yin, Yun Deng, Oleg Murashko, Yuequn Wang, Xiongwei Fan, Chuanbing Zhu, Karen Ocorr, Rolf Bodmer, and Xiushan Wu. Znf418, a novel human krab/c2h2 zinc finger protein, suppresses mapk signaling pathway. Molecular and Cellular Biochemistry, 310(1–2):141–151, December 2007. URL: http://dx.doi.org/10.1007/s11010-007-9674-4, doi:10.1007/s11010-007-9674-4. This article has 21 citations and is from a peer-reviewed journal.](https://doi.org/10.1007/s11010-007-9674-4)